Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
Previously, we designed the EuK-based PSMA ligand BQ0413 with an maE<sub>3</sub> chelator for labeling with technetium-99m. It showed efficient tumor targeting, but our preclinical data and preliminary clinical results indicated that the renal excretion levels need to be decreased. We hy...
Main Authors: | Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/25/7/3615 |
Similar Items
-
Preclinical Evaluation of a Novel High-Affinity Radioligand [<sup>99m</sup>Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)
by: Ekaterina Bezverkhniaia, et al.
Published: (2023-12-01) -
Synthesis and preclinical evaluation of novel 99mTc-labeled PSMA ligands for radioguided surgery of prostate cancer
by: Jan-Philip Kunert, et al.
Published: (2023-01-01) -
A Review on the Current State and Future Perspectives of [<sup>99m</sup>Tc]Tc-Housed PSMA-i in Prostate Cancer
by: Sara Brunello, et al.
Published: (2022-04-01) -
Technetium-99m in production and use
by: Vučina Jurij, et al.
Published: (2009-01-01) -
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
by: Fanny Lundmark, et al.
Published: (2022-05-01)